{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["72(2)"],"submitter":["Karris MY"],"funding":["NICHD NIH HHS","NIAID NIH HHS","NIMH NIH HHS"],"journal":["Journal of acquired immune deficiency syndromes (1999)"],"pagination":["e48-50"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4867124"],"repository":["biostudies-literature"],"pubmed_title":["Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue."],"pmcid":["PMC4867124"],"funding_grant_id":["R01 MH100974","P30 AI036214","R24 AI106039","R01 HD083042"],"pubmed_authors":["Jain S","Diamond C","Haubrich RH","Rieg G","Karris MY","Kemper C","Sun X","Dube MP","Kerkar S","Morris S","Goicoechea M","Daar ES","California Collaborative Treatment Group (CCTG) 589 Study Team","Bowman VQ"],"additional_accession":[]},"is_claimable":false,"name":"Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue.","description":null,"dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Jun","modification":"2025-04-26T10:55:08.504Z","creation":"2025-04-06T13:28:24.648Z"},"accession":"S-EPMC4867124","cross_references":{"pubmed":["26977746"],"doi":["10.1097/QAI.0000000000000990","10.1097/qai.0000000000000990"]}}